Walgreens, the retail pharmacy giant, announced disappointing third-quarter earnings and slashed its full-year profit outlook due to a challenging consumer environment. The company now expects fiscal 2024 adjusted earnings of $2.80 to $2.95 per share, down from the previous outlook of between $3.20 and $3.35 per share (CNBC, Reuters).
CEO Tim Wentworth stated that consumer spending will be weaker for the rest of the year (NBC News). In response to this trend, Walgreens is finalizing a significant multi-year program to close some of its underperforming U.S. stores and implement cost-cutting measures (Reuters).
The pharmacy chain has faced difficulties for years, including declining share prices, reduced prescription drug revenues, and pressure from competitors like Amazon and big-box chains such as CVS (NBC News). In an interview with CNBC, Wentworth stated that the consumer is stunned by the absolute prices of things and that they have had to get really keen in discretionary things (NBC News).
Walgreens has been undergoing a transformation into a large health-care company, focusing on its health-care segment as a critical part of this push. However, the challenging consumer environment and financial strain have hindered these efforts (CNBC).
The company's stock dropped significantly after the earnings report, with shares falling nearly 20% on Thursday (Reuters). Analysts expect an annual profit of $3.20 per share for Walgreens, but the forecast cut weighed on rival CVS Health's stock as well, sending it about 5% lower in early trade (Reuters).
Walgreens has already closed 484 stores in the UK and 625 stores in the U.S., according to a regulatory filing. The company is open to closing down more stores beyond those being reviewed as part of its multi-year program (Reuters).